Magnesium Carbonate Dosage
Applies to the following strengths: 54 mg/5 mL; 5%; 250 mg
Usual Adult Dose for:
Usual Pediatric Dose for:
Additional dosage information:
Usual Adult Dose for Dietary Supplement
Recommended dietary intake (RDA) for magnesium:
18 years, male: 410 mg
18 years, female: 360 mg
19 to 30 years, male: 400 mg
19 to 30 years, female: 310 mg
31 years and older, male: 420 mg
31 years and older, female: 320 mg
Tolerable upper intake level (UL) for supplemental magnesium: 350 mg
Usual Adult Dose for Dyspepsia
10 mL (250 mg/5 mL suspension) orally every 3 to 4 hours as needed
Maximum dose: 40 mL/day
Duration of therapy: Up to 2 weeks
Usual Pediatric Dose for Dietary Supplement
Recommended dietary intake (RDA) for magnesium:
Birth to 6 months: 30 mg (adequate intake)
7 to 12 months: 75 mg (adequate intake)
1 to 3 years: 80 mg
4 to 8 years: 130 mg
9 to 13 years: 240 mg
14 to 18 years, male: 410 mg
14 to 18 years, female: 360 mg
Tolerable upper intake level (UL) for supplemental magnesium:
1 to 3 years: 65 mg
4 to 8 years: 110 mg
9 to 18 years: 350 mg
Usual Pediatric Dose for Dyspepsia
12 years and older: 10 mL (250 mg/5 mL suspension) orally every 3 to 4 hours as needed
Maximum dose: 40 mL/day
Duration of therapy: Up to 2 weeks
6 to 12 years: 5 mL (250 mg/5 mL suspension) orally every 3 to 4 hours as needed
Maximum dose: 20 mL/day
Duration of therapy: Up to 2 weeks
Renal Dose Adjustments
Use with caution.
- Hypermagnesemia risk is increased in renal impairment.
- The risk of magnesium toxicity is increased in renal impairment and failure because of reduced ability to remove excess magnesium.
- In mild renal impairment, fractional excretion of magnesium increases to compensate for loss of glomerular filtration, but this becomes inadequate by the time creatinine clearance is under 30 mL/min.
- Hypermagnesemia is common with creatinine clearance under 10 mL/min.
- Monitor magnesium levels.
- Use as a carminative is not recommended in renal impairment.
Liver Dose Adjustments
Data not available
Dialysis
Dose adjustment(s) may be required; however, no specific guidelines have been suggested. Caution is recommended.
- Effects are similar in both hemodialysis and peritoneal dialysis.
- Hypermagnesemia is common with creatinine clearance under 10 mL/min.
- Mild hypermagnesemia is common with a dialysate magnesium of 0.75 mmol/L
- Serum magnesium was normal to low with a dialysate magnesium between 0.2 and 0.25 mmol/L.
- Ionized serum, ionized mononuclear and red blood cell measurements are not useful for hypermagnesemia detection.
Other Comments
Administration advice:
- Shake suspension well before using.
Patient advice:
- This drug may have a laxative effect.
More about magnesium carbonate
- Check interactions
- Compare alternatives
- Reviews (1)
- Side effects
- During pregnancy
- Drug class: minerals and electrolytes
Patient resources
Other brands
Related treatment guides
See also:
Carafate
Carafate is an anti-ulcer medication used to treat active duodenal ulcers. Learn about side ...
Renvela
Renvela (sevelamer) reduces blood levels of phosphorus in people with chronic kidney disease who ...
Ozempic
Learn about Ozempic (semaglutide) for type 2 diabetes treatment, weight management, cardiovascular ...
Ibsrela
Ibsrela (tenapanor) is used for the treatment of irritable bowel syndrome with constipation ...
Velphoro
Velphoro (sucroferric oxyhydroxide) is used to treat hyperphosphatemia in chronic kidney disease ...
Auryxia
Auryxia is used for hyperphosphatemia of renal failure, iron deficiency anemia
Xphozah
Xphozah (tenapanor) is a phosphate absorption inhibitor that is used lower serum phosphorus levels ...
Fosrenol
Fosrenol (lanthanum carbonate) reduces phosphate levels in patients with end stage renal disease ...
Renagel
Renagel (sevelamer) is used to reduce levels of phosphorus in people with kidney disease who are on ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.